Chandra Bhagat Pharma Limited, initially founded as Chandra Bhagat Pharma Private Limited in 2003, is a Mumbai-based pharmaceutical company specializing in the marketing of critical care and healthcare products. Following its conversion to a public limited company in 2019, the company has expanded its reach in both domestic and international markets. Founded by Mr. Hemant Bhagat and the late Shree Chandravadan Bhagat, Chandra Bhagat Pharma acquired the business of M/s. Chandra Bhagat Corporation in 2003, establishing a strong foundation in pharmaceuticals.
The company boasts a diverse portfolio, focusing on life-saving medicines across various therapeutic categories, including oncology, antibiotics, cardiovascular, hormones, and more. It collaborates with contract manufacturers to produce pharmaceutical formulations such as injections and tablets, and promotes Active Pharmaceutical Ingredients (APIs) within India. With FDA approvals and a robust marketing strategy, the company continues to enhance its presence in both domestic and export markets.
